Eisai, Purdue Pharma announce significant data of ph 3 clinical study

Clinical Research |  News | 0 Comment | 04 Feb, 2019

Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study evaluating the efficacy and safety of lemborexant, an investigational...Read more

Spero Therapeutics announces initiation of SPR720 Ph 1 Clinical Trial

Clinical Research |  News | 0 Comment | 31 Jan, 2019

Spero Therapeutics,  a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacter...Read more

Ionis, Roche initiates pivotal study of RG6042 for Huntington's disease

Clinical Research |  News | 0 Comment | 30 Jan, 2019

Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the first patient in a pivotal study of RG6042 (IONIS-HTTRx) for people livin...Read more

NIAID-sponsored trial of Ebola vaccines begins at Cincinnati Children's Hospital

Clinical Research |  News | 0 Comment | 29 Jan, 2019

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United Sta...Read more

Dicerna announces start of Ph1 clinical trial of DCR-HBVS

Clinical Research |  News | 0 Comment | 29 Jan, 2019

Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the first human volunteer in its Phase 1 clinical trial of DCR-HBVS, the ...Read more

OliX announces clinical candidate for Geographic Atrophy treatment

Clinical Research |  News | 0 Comment | 29 Jan, 2019

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clinical candidate for the treatment of Geographic Atrophy (GA), which is...Read more

Translate Bio announces FDA clinical hold on IND

Clinical Research |  News | 0 Comment | 23 Jan, 2019

Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunct...Read more

Gamida Cell collaborates with Be The Match BioTherapies

Clinical Research |  News | 0 Comment | 23 Jan, 2019

Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program/Be The Match offering integrated platforms and so...Read more

Redx to resume RXC004 clinical trial programme

Clinical Research |  News | 0 Comment | 22 Jan, 2019

UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given formal approval to the Company to re-commence the...Read more

Abcam, Loulou Foundation enters research collaboration for CDKL5 deficiency disorder

Clinical Research |  News | 0 Comment | 22 Jan, 2019

Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation dedicated to the development of therapeutics for CDKL5 Deficiency Diso...Read more

TaiwanJ Pharma announces new clinical results on AIH drug

Clinical Research |  News | 0 Comment | 22 Jan, 2019

TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small molecules for unmet medical needs such as NASH and Cancers, recently ...Read more

Lilly reports results of ANNOUNCE

Clinical Research |  News | 0 Comment | 21 Jan, 2019

Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combination with doxorubicin in patients with advanced or metastatic soft tis...Read more

AIVITA gets IND nod for Phase 1B melanoma trial

Clinical Research |  News | 0 Comment | 17 Jan, 2019

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New ...Read more

United Neuroscience gets positive results from Ph2a trial for Alzheimer's vaccine

Clinical Research |  News | 0 Comment | 17 Jan, 2019

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders has announced positive top-line results from its Phase 2a...Read more

Bridge Bio receives FDA ODD for IPF drug

Clinical Research |  News | 0 Comment | 17 Jan, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the U.S. Food and Dr...Read more

Immunocore names David Berman as Head of R&D

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development. Over his career, David has worked on immuno-oncology programmes at ...Read more

Innovent announces dosing of patient in a Ph1 clinical trial of Anti-CD47 MAb

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has announced that the first patient has been successfully dosed in a pha...Read more

NIH starts clinical trial for FMT

Clinical Research |  News | 0 Comment | 15 Jan, 2019

A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema—putting stool from a healthy donor...Read more